Read + Write + Report
Home | Start a blog | About Orble | FAQ | Blogs | Writers | My Orble | Login

Australian Business News - by Fernando Monteiro

Foster’s: Time For A Beer

November 24th 2006 16:38
If you, dear reader, drink beer, would you tell me when was it the last time its price went down?

The news today, 24 November 2006, is that the world’s largest brewer, the Belgian based InBev is bidding $15.2 billion or $7.50 a share for Foster’s. Foster’s shares closed today at $6.89.

Foster’s has been sought after since August for acquisition purposes by InBev, SAB Miler, the Sultan of Brunei and some private equity funds.

InBev requested its advisers to value Foster’s brewing business, including brands such as Carlton Draught and Victoria Bitter.

InBev is not apparently interested in the wine business owned by Foster’s such as Allied Domecq and Diageo. For Foster’s, according to some, divesting these business at this time may make sense.


This news was published in the online version of The Age, under the title “Foster’s cup runneth over on takeover rumours” and was written by Rebecca Urban. Click here to open this page: http://www.theage.com.au/news/business/fosters-cup-runneth-over-on-takeover-rumours/2006/11/23/1163871549599.html.

Foster’s (ASX: FGL) is a fantastic company which found a way to successfully market its product internationally.

Foster’s Net Profit After Tax grew in the last six years by 20 per cent compounded. Its current NPAT is $1,166.2 million, its Net Profit Margin is 11.9 per cent and its Return On Equity is 13.7 per cent which, all together, is just great.

Not surprisingly, its share price in the last 10 years almost tripled. And it pays a dividend of 21.5 cents for a Yield of 3.12 per cent.

FGL P/E, though, is almost 23 times making it look expensive. In comparison with Bonds, however, it results favourable: bond value is $19,437 million and capitalisation $13,964 million.


Foster’s has a very strong and visible brand name and is able to regularly increase the price of its products. Not surprisingly, its Operating Cash Flows have been growing at a rate of 23 per cent compounded.

Foster’s has also been expanding into other areas such as wine production, without much success and, as mentioned above, it may take the chance to divest it.

Another area of expansion of Foster’s has been non-alcohol drinks such as Torquay, Cascade Ginger Beer, Cascade Real Juices and others.

It has been speculated that it could expand into milk based drinks which have large margins.

All together, I envisage a great future for Foster’s.

So, if you own shares in FGL, would you drink an extra beer today?

End
48
Vote
   


Qantas: Would You Sell To Foreigners?

November 23rd 2006 11:05
How would you feel, dear reader, if the Flying Kangaroo suddenly became a foreign entity?

The news today, 23 November 2006, is that Qantas is being preyed by two prospective buyers: a US private equity firm, Texas Pacific Group and Macquarie Bank Ltd.

The buyout could be of as much as $11 billion or $5.50 a share.

Sydney-based Allco Finance Group Ltd, a company which operates aircraft leasing, is also considering taking part in the consortium.

There are, though, “numerous stakeholder issues involving the federal government, Qantas management, unions, the competition regulator and airline partners,” Paul Ryan from Goldman Sachs JBWere said.

One of the problems is that the Qantas act limits foreign investment in it to 49 per cent of the airline total and also limits individual shareholders, foreign or local, to 25 per cent.

This news was published in the online version of the Sydney Morning Herald, under the title “A takeover of Qantas is difficult: analysts”. Click here to open this page: http://www.smh.com.au/news/business/a-takeover-of-qantas-is-difficult-analysts/2006/11/23/1163871539944.html?page=fullpage#contentSwap1.

Qantas (ASX: QAN) is certainly a prosperous business. Its current Net Profit After Tax is $479.5 million and it’s selling for a multiple of 17 times to its EPS of 28.8 cents. Today’s share price is $4.93.

It displays also strong Operating Cash Flows, being the current per share figure 104.8 cents.

Its Return On Equity, though, on average for the last six years, is unimpressive at 10 per cent.

A worrying feature of Qantas is its debt. Long Term Debt is $5,785.8 million or 49 per cent of Capital (Equity plus Debt). If Qantas had to repay its debt with the whole of its net profit it would take 12 years to do it.

The question about Qantas now is not its prosperity but its symbology. The Flying Kangaroo is a national symbol and many Aussies own a share of it—and want to keep it that way.

The hurdles for the predators in this tale are many and great. Will they manage to take Qantas away? It’s a story worth following.

End
56
Vote
   


If you, dear reader, like retail would you go on a world foray with Harvey Norman?

The news today, 22 November 2006, is that Gerry Harvey, after announcing yesterday strong four-month figures for Rebel Sport and Harvey Norman, said “we are trying to become a world retailer.”

“That’s our ambition. No one else has done it in Australian history.” “We would like to sit here in 15 to 20 years’ time and say we knocked the buggers off.”

Part of the work would be to win over English retailers Dixon’s and Curry’s. Mr Harvey said he would first expand first through Ireland as a form of cautionary measure.

The company also plans to open three stores more in Malaysia to a total of 15.

This news was published in the online version of The Age, under the title “Norman conquest Harvey world view” and was written by Vanda Carson. Click here to open this page: http://www.theage.com.au/news/business/norman-conquest-harvey-world-view/2006/11/21/1163871404677.html.

Harvey Norman (ASX: HVN) is one of the most successful retail stories in Australia. It holds a total of 174 Australian stores and about 30 international ones, totalling sales of $1.7 billion in figures for the four months to October.

Its revenues grew 27 per cent on an annual compounded basis since June 2001. It’s a fact also that the Australian territory is now saturated. So, will HVN recreate its growth success story by expanding overseas? That seems to be the determination of its Chairman, Gerry Harvey.

The English market may be hard to penetrate and the Asian markets may follow a different formula. But Mr Harvey is creative and astute.

HVN’s earnings have been growing by 16 per cent in the last five years. If they keep going this way, in 2011 they would be 43.65 cents. Having in account average multiples of 27, the share price, now $4.06, would then be $11.78, for an annual return of 24 per cent compounded.

That is, if HVN succeeds in its foreign expansion.

End
50
Vote
   


Aristocrat: Who Likes Playing Poker?

November 21st 2006 12:12
If you, dear reader, like playing the poker, would you buy Aristocrat?

The news today, 21 November 2006, is that analysts believe Aristocrat Leisure will grow steadily for the next three years. Goldman Sachs JBWere sees Aristocrat’s growth as “very solid” expecting 20 per cent EPS growth for the next three years


[ Click here to read more ]
50
Vote
   


Telstra T3: Would You Buy?

November 20th 2006 10:20
Would you, my reader, buy today shares in Telstra T3?

The news today, 20 November 2006, are that Finance Minister Nick Minchin said investment banks responsible for the $15.5 billion Telstra share sale have “earned every single penny” of the more than $100 million they will collectively receive


[ Click here to read more ]
62
Vote
   


Who Wants to Invest in India’s Growth?

November 17th 2006 17:00
If you, my reader, are a businessperson, would you do business in India today?

The news today, 17 November 2006, is that “the penny has dropped on doing business with India.” This was said by Mr Moignard, Austrade’s senior trade commissioner for South Asia, who added that India “has captured people’s imagination


[ Click here to read more ]
55
Vote
   


ChemGenex: Who Likes Biotechs?

November 16th 2006 11:59
If you, dear reader, are an investor, do you buy biotech stocks?

The news today, 16 November 2006, is that Melbourne based biotech company ChemGenex “has won the right for its lead drug to be accelerated through the US Food and Drug Administration approval process


[ Click here to read more ]
56
Vote
   


More Posts
7 Posts
7 Posts dating from November 2006
Email Subscription
Receive e-mail notifications of new posts on this blog:

Fernando Monteiro's Blogs

2401 Vote(s)
6 Comment(s)
37 Post(s)
371 Vote(s)
2 Comment(s)
8 Post(s)
3161 Vote(s)
6 Comment(s)
51 Post(s)
Moderated by Fernando Monteiro
Copyright © 2006 2007 2008 On Topic Media PTY LTD. All Rights Reserved. Design by Vimu.com.
On Topic Media ZPages: Sydney |  Melbourne |  Brisbane |  London |  Birmingham |  Leeds     [ Advertise ] [ Contact Us ] [ Privacy Policy ]